Management of depression induced by interferon hepatitis therapies

Primary Care Companion to the Journal of Clinical Psychiatry

Volumn 15, Issue 5, 2013, Pages

  Shah, Hema ^a   Kadia, Snehal ^a   Bawa, Radhika ^a   Lippmann, Steven ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CITALOPRAM; CORTICOTROPIN; DEXMETHYLPHENIDATE; ESCITALOPRAM; HYDROCORTISONE; INTERFERON; INTERLEUKIN 6; INTERLEUKIN 8; METHYLPHENIDATE; MODAFINIL; PAROXETINE; PLACEBO; RIBAVIRIN; SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

ANOREXIA; ARTICLE; CORTICOTROPIN BLOOD LEVEL; DEPRESSION; DIARRHEA; DISEASE SEVERITY; DROWSINESS; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FATIGUE; GASTROINTESTINAL HEMORRHAGE; HEPATITIS C; HUMAN; HYDROCORTISONE BLOOD LEVEL; LONG TERM CARE; MOOD DISORDER; NAUSEA; PAIN; PREVALENCE; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETINOPATHY; SEXUAL DYSFUNCTION; SIDE EFFECT; SYMPTOMATOLOGY; SYSTEMATIC REVIEW; TREATMENT INDICATION; WEIGHT GAIN;

EID: 84888126910     PISSN: 15235998     EISSN: 1555211X     Source Type: Journal    
DOI: 10.4088/PCC.12r01487     Document Type: Article

References (15)

1. Viral Hepatitis Statistics and Surveillance. Centers for Disease Control and Prevention Web site. http://www.cdc.gov/hepatitis/statistics/index.htm. Updated June 22, 2012. Accessed October 24, 2012.
2. Interferon. MedicineNet Web site. http://www.medicinenet.com/interferon/article.htm. Updated March 30, 2010. Accessed October 25, 2012.
3. Schaefer M, Sarkar R, Knop V, et al. Escitalopram for the prevention of peginterferon-α2a-associated depression in hepatitis C virus-infected patients without previous psychiatric disease: a randomized trial. Ann Intern Med. 2012;157(2):94-103. PubMed doi:10.7326/0003-4819-157-2-201207170-00006 Show Abstract Show Abstract
4. Crone CC, Gabriel GM, Wise TN. Managing the neuropsychiatric side effects of interferon-based therapy for hepatitis C. Cleve Clin J Med. 2004;71(suppl 3):S27-S32. PubMed doi:10.3949/ccjm.71.Suppl_3.S27 Show Abstract Show Abstract
5. Gleason OC, Fucci JC, Yates WR, et al. Preventing relapse of major depression during interferon-alpha therapy for hepatitis C: a pilot study. Dig Dis Sci. 2007;52(10):2557-2563. PubMed doi:10.1007/s10620-006-9729-5 Show Abstract Show Abstract
6. Asnis GM, De La Garza R 2nd. Interferon-induced depression: strategies in treatment. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29(5):808-818. PubMed doi:10.1016/j.pnpbp.2005.03.006 Show Abstract Show Abstract
7. de Knegt RJ, Bezemer G, Van Gool AR, et al. Randomised clinical trial: escitalopram for the prevention of psychiatric adverse events during treatment with peginterferon-alfa-2a and ribavirin for chronic hepatitis C. Aliment Pharmacol Ther. 2011;34(11-12):1306-1317. PubMed doi:10.1111/j.1365-2036.2011.04867.x Show Abstract Show Abstract
8. Gleason OC, Yates WR, Philipsen MA. Major depressive disorder in hepatitis C: an open-label trial of escitalopram. Prim Care Companion J Clin Psychiatry. 2005;7(5):225-230. PubMed doi:10.4088/PCC.v07n0503 Show Abstract Show Abstract
9. Alberti A. What are the comorbidities influencing the management of patients and the response to therapy in chronic hepatitis C? Liver Int. 2009;29(suppl 1):15-18. PubMed doi:10.1111/j.1478-3231.2008.01945.x Show Abstract Show Abstract
10. Morasco BJ, Rifai MA, Loftis JM, et al. A randomized trial of paroxetine to prevent interferon-alpha-induced depression in patients with hepatitis C. J Affect Disord. 2007;103(1-3):83-90. PubMed doi:10.1016/j.jad.2007.01.007 Show Abstract Show Abstract
11. Raison CL, Woolwine BJ, Demetrashvili MF, et al. Paroxetine for prevention of depressive symptoms induced by interferon-alpha and ribavirin for hepatitis C. Aliment Pharmacol Ther. 2007;25(10):1163-1174. doi:10.1111/j.1365-2036.2007.03316.x PubMed
12. Raison CL, Demetrashvili M, Capuron L, et al. Neuropsychiatric adverse effects of interferon-α: recognition and management. CNS Drugs. 2005;19(2):105-123. PubMed doi:10.2165/00023210-200519020-00002 Show Abstract Show Abstract
13. Lotrich F. Inflammation, interferon-alpha and depression. Psychiatr Ann. 2012;42(9):317-321. doi:10.3928/00485713-20120906-04
14. Diez-Quevedo C, Masnou H, Planas R, et al. Prophylactic treatment with escitalopram of pegylated interferon alfa-2a-induced depression in hepatitis C: a 12-week, randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2011;72(4):522-528. doi: 10.4088/JCP.09m05282blu PubMed Show Abstract Show Abstract
15. Selective serotonin reuptake inhibitors. Mayo Clinic Web site. http://www.mayoclinic.com/health/ssris/MH00066. Updated December 9, 2010. Accessed October 24, 2012.